1. Conn JW. Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 1965;273:1135-43.
[CROSSREF] [PUBMED]
2. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA 2015;314:1021-9.
[CROSSREF] [PUBMED]
3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5-20.
[CROSSREF] [PUBMED]
4. Kannel WB, Wilson PW, Zhang TJ. The epidemiology of impaired glucose tolerance and hypertension. Am Heart J 1991;121(4 Pt 2):1268-73.
[CROSSREF] [PUBMED]
5. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006;91:454-9.
[CROSSREF] [PUBMED]
6. Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007;116:984-92.
[CROSSREF] [PUBMED]
7. Chen W, Li F, He C, Zhu Y, Tan W. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Ir J Med Sci 2014;183:283-91.
[CROSSREF] [PUBMED]
8. Wu VC, Hu YH, Er LK, Yen RF, Chang CH, Chang YL, et al. Case detection and diagnosis of primary aldosteronism: the consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc 2017;116:993-1005.
[CROSSREF] [PUBMED]
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9.
[CROSSREF] [PUBMED] [PMC]
10. Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, et al. Latent autonomous cortisol secretion from apparently nonfunctioning adrenal tumor in nonlateralized hyperaldosteronism. J Clin Endocrinol Metab 2019;104:4382-9.
[CROSSREF] [PUBMED]
11. Lee CH, Shih AZ, Woo YC, Fong CH, Leung OY, Janus E, et al. Optimal cut-offs of homeostasis model assessment of insulin resistance (HOMA-IR) to identify dysglycemia and type 2 diabetes mellitus: a 15-year prospective study in Chinese. PLoS One 2016;11:e0163424.
[CROSSREF] [PUBMED] [PMC]
12. Hin LY, Lau TK, Rogers MS, Chang AM. Dichotomization of continuous measurements using generalized additive modelling: application in predicting intrapartum caesarean delivery. Stat Med 1999;18:1101-10.
[CROSSREF] [PUBMED]
13. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477-90.
[CROSSREF] [PUBMED]
14. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-94.
[CROSSREF] [PUBMED] [PMC]
15. Tsurutani Y, Sugisawa C, Ishida A, Inoue K, Saito J, Omura M, et al. Aldosterone excess may inhibit insulin secretion: a comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism. Endocr J 2017;64:339-46.
[CROSSREF] [PUBMED]
16. Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, et al. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension 2006;48:1050-7.
[CROSSREF] [PUBMED]
17. Wada T, Ohshima S, Fujisawa E, Koya D, Tsuneki H, Sasaoka T. Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes. Endocrinology 2009;150:1662-9.
[CROSSREF] [PUBMED]
18. Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007;30:2349-54.
[CROSSREF] [PUBMED]
19. Giacchetti G, Sechi LA, Rilli S, Carey RM. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 2005;16:120-6.
[CROSSREF] [PUBMED]
20. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985;75:809-17.
[CROSSREF] [PUBMED] [PMC]
21. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
[CROSSREF] [PUBMED]
22. Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YD, Reaven GM. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988;66:580-3.
[CROSSREF] [PUBMED]
23. Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, et al. Is primary aldosteronism associated with diabetes mellitus?: results of the German Conn’s Registry. Horm Metab Res 2010;42:435-9.
[CROSSREF] [PUBMED]
24. Wu VC, Chueh SJ, Chen L, Chang CH, Hu YH, Lin YH, et al. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years. J Hypertens 2017;35:1698-708.
[CROSSREF] [PUBMED]
25. Gerards J, Heinrich DA, Adolf C, Meisinger C, Rathmann W, Sturm L, et al. Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. J Clin Endocrinol Metab 2019;104:3192-202.
[CROSSREF] [PUBMED]
26. Williams TA, Lenders JW, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017;5:689-99.
[CROSSREF] [PUBMED] [PMC]
27. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
[CROSSREF] [PUBMED]
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
[CROSSREF] [PUBMED]